A new collaboration will use live tumor analysis to evaluate the investigational therapy TES-4207 for lung cancer.
Live Poll
Do you believe pharmaceutical research partnerships generally improve the development of new cancer therapies?
September 24, 2026
Mechanism Found for Cancer Immunotherapy ResistanceResearchers identified a molecular pathway that allows esophageal cancer cells to evade immune treatment.
September 24, 2026
Novel T Cell Therapy Targeted Resistant GlioblastomaResearchers found that a new cell-based therapy could shrink chemotherapy-resistant brain tumors in preclinical models.
September 24, 2026
Safety Standards Enhanced for Nontraditional ChemotherapyNew protocols help ensure patient safety when chemotherapy is administered outside of dedicated oncology wards.
September 24, 2026
New Ovarian Cancer Trial Results Will Be PresentedNew findings for a dual-drug therapy in low-grade serous ovarian cancer will be shared at a global conference in October.
September 24, 2026
Molecular Pathway Linked to Colorectal Cancer ProgressionResearchers identified how specific proteins enable tumor growth and hinder chemotherapy effectiveness.
September 24, 2026
Kidney Cancer Metabolism Insights Have Been ReviewedResearchers identified how common tumor gene changes shift how cancer cells grow, potentially pointing toward new treatment targets.
September 24, 2026
Neem Leaf Oil Induced Cancer Cell Death in Lab StudyResearchers observed that colorectal cancer cells showed higher rates of programmed cell death when exposed to essential oil from Azadirachta indica.
September 24, 2026
Lung Cancer Radiation Linked to Thymus DamageNew research suggests that exposing the thymus to radiation during treatment may impact long-term survival outcomes.
September 24, 2026
Global Cancer Burden Has Faced Significant ProjectionsExperts met in Hong Kong to address inequities in cancer care and rising case numbers predicted for the next decade.
September 24, 2026
Stoma Site Cell Ratios Linked to Cancer PrognosisResearchers found that specific immune cell levels at the stoma site may help predict outcomes for colorectal cancer patients.
